HIGHLIGHTS
- who: Fen Feng et al. from the Cancer Center, The First People's Hospital of Foshan City, Foshan, China have published the research work: Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer, in the Journal: Journal of Oncology of 13/07/2022
- what: To MSI status the authors aimed to reveal the potential predictive value of adenomatous polyposis coli (APC) gene mutations in CRC patients. The authors also observed lower percentage of NK T_cell, Treg cells, and fibroblasts cells and more high-grade immune subtypes (C2-C4) in the APC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.